Bioregenx (BRGX) Invested Capital (2021 - 2026)

Bioregenx's Invested Capital history runs 6 years deep, the most recent figure standing at -$4.4 million for Q1 2026.

• In Q1 2026, Invested Capital fell 80.17% year-over-year to -$4.4 million; the TTM figure through Mar 2026 stood at -$4.4 million (down 80.17% YoY), while the FY2025 annual figure was -$4.4 million, down 94.92% from the prior year.
• Invested Capital was -$4.4 million for Q1 2026 at Bioregenx, roughly flat from -$4.4 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $16.0 million in Q1 2024 to a low of -$4.4 million in Q4 2025.
• Historically, Invested Capital has averaged $899852.3 across 5 years, with a median of -$2.2 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Invested Capital tumbled 2110.9% in 2022, then surged 824.46% in 2024.
• A 5-year view of Invested Capital shows it stood at -$2.3 million in 2022, then jumped by 33.6% to -$1.5 million in 2023, then slumped by 45.0% to -$2.2 million in 2024, then plunged by 94.92% to -$4.4 million in 2025, then advanced by 0.16% to -$4.4 million in 2026.
• The last three Invested Capital figures came in at -$4.4 million (Q1 2026), -$4.4 million (Q4 2025), and -$2.6 million (Q3 2025), per Business Quant data.